In the last week, a joint bid for Allergan, the maker of Botox, has evolved from an already unusual deal into one of the most confounding takeover attempts in recent memory.
via NYT > Business Day http://ift.tt/1ooUiCz
via WordPress http://ift.tt/1nIC4Qq
No comments:
Post a Comment